Solution1 Observed2 Expected3 %O/E4
4 — 20.2 — —
A 27.7 25.4 109%
B 33.0 31.7 104%
C 44.5 44.2 101%
Method Comparison 1
Homocysteine | 40 |
| 30 |
2000 | 20 |
IMMULITE | 10 |
| |
| 0 |
0 | 10 | 20 | 30 | 40 |
|
| Kit A, µmol/L |
|
|
(IML 2000) = 1.0 (Kit A) + 0.024 µmol/L r = 0.966
Method Comparison 2
Homocysteine2000 | 50 |
20 | |
| 40 |
| 30 |
IMMULITE | 10 |
| |
| 0 |
0 | 10 | 20 | 30 | 40 | 50 |
HPLC, µmol/L
(IML 2000) = 0.97 (HPLC) + 0.71 µmol/L r = 0.974
Method Comparison 3
2000Homocysteine | 20 |
10 | |
| 15 |
IMMULITE | 5 |
|
5 | 10 | 15 | 20 | 25 |
Kit B, µmol/L
(IML 2000) = 0.90 (Kit B) – 0.02 µmol/L r = 0.925
Effect of Storage Temperature on Different Sample Types
Graph 1: HeparinGraph 2: EDTAIMMULITE 2000 Homocysteine | 7 |